Pressrelease 15 May 2007
Promising Results in Treatment with GLX
Treatment with GLX causes improvement in hyperglycemia in Goto-Kakizaki Rats.
The effect of GLX treatment was investigated in diabetic Goto-Kakizaki (GK) rats, a genetic model for Type 2 diabetes and the GK rats showed significantly lowered levels of blood glucose after treatment.
These promising results put forward the probability to develop a pharmaceutical antidiabetic treatment by Glucox Biotech’s strategy and GLX has the potential to be a new therapeutic candidate for the treatment of type 2 diabetes.
Download a pdf of the Pressrelease
Pressrelease 15 May 2007
Promising Results in Treatment with GLX
Pressrelease 29 December 2006
US Patent Received for Diabetes Treatment
Pressrelease 28 September 2006
Glucox' Unique Research Discovery Confirmed by US Scientist
Pressrelease 10 July 2006
Patent Application Submitted for the GLX Compounds
Pressrelease 5 June 2006
A Significant Preclinical Milestone Achieved
Pressrelease 7 February 2006
Positive Results from the First Time In Animal Study
Pressrelease 10 January 2006
Pressrelease 10 November 2005
Evaluation and Selection of Glucox Biotech' Lead Drug Candidates